Abstract:BackgroundGout treatment is suboptimal despite available therapy, with low levels of initiation and persistence of urate-lowering therapy (ULT) in many patients.AimTo identify all interventions that have attempted to improve the uptake of ULT and analyse the clinical outcomes.Design & settingA systematic review of international articles pub… Show more
“…Pharmacist‐led care can yield success rates of 35%‐82% 7‐9 . Other interventions focusing on education, goal setting and reinforcement in a variety of settings have also shown promising results 1 …”
mentioning
confidence: 99%
“…This is slowly changing in small pockets though, for example, with the tsunami of type 2 diabetes mellitus a large team of critical healthcare professionals in the form of diabetes nurse educators, nutritionists, dieticians and nurse practitioners often provide a large proportion of the required care. We now have a growing body of literature from around the world that adapting care from traditional models to meet the needs of patients with gout can dramatically improve outcomes 1 . Gout needs to have its “type 2 diabetes moment” and be recognized as an important problem that requires a disease‐specific solution to address.…”
mentioning
confidence: 99%
“…Research has identified patient, provider and health system issues as contributing to these poor outcomes. However, there have been a series of studies demonstrating the value of alternate models of care in gout 1 . Standard models in primary care yield rates of reaching serum urate (SU) targets of between 22%‐30% 2‐4 .…”
mentioning
confidence: 99%
“…[7][8][9] Other interventions focusing on education, goal setting and reinforcement in a variety of settings have also shown promising results. 1 Kee Fong Phang and colleagues report on a model of gout care that is nurse-led, rheumatologist-assisted telemedicine partnered with regional primary healthcare centers in Singapore. 10 Included patients had rheumatologist-diagnosed gout who required urate-lowering therapy (ULT).…”
mentioning
confidence: 99%
“…We now have a growing body of literature from around the world that adapting care from traditional models to meet the needs of patients with gout can dramatically improve outcomes. 1…”
Despite effective therapies being available, gout remains a rheumatic disease with poor patient outcomes. Research has identified patient, provider and health system issues as contributing to these poor outcomes. However, there have been a series of studies demonstrating the value of alternate models of care in gout. 1
“…Pharmacist‐led care can yield success rates of 35%‐82% 7‐9 . Other interventions focusing on education, goal setting and reinforcement in a variety of settings have also shown promising results 1 …”
mentioning
confidence: 99%
“…This is slowly changing in small pockets though, for example, with the tsunami of type 2 diabetes mellitus a large team of critical healthcare professionals in the form of diabetes nurse educators, nutritionists, dieticians and nurse practitioners often provide a large proportion of the required care. We now have a growing body of literature from around the world that adapting care from traditional models to meet the needs of patients with gout can dramatically improve outcomes 1 . Gout needs to have its “type 2 diabetes moment” and be recognized as an important problem that requires a disease‐specific solution to address.…”
mentioning
confidence: 99%
“…Research has identified patient, provider and health system issues as contributing to these poor outcomes. However, there have been a series of studies demonstrating the value of alternate models of care in gout 1 . Standard models in primary care yield rates of reaching serum urate (SU) targets of between 22%‐30% 2‐4 .…”
mentioning
confidence: 99%
“…[7][8][9] Other interventions focusing on education, goal setting and reinforcement in a variety of settings have also shown promising results. 1 Kee Fong Phang and colleagues report on a model of gout care that is nurse-led, rheumatologist-assisted telemedicine partnered with regional primary healthcare centers in Singapore. 10 Included patients had rheumatologist-diagnosed gout who required urate-lowering therapy (ULT).…”
mentioning
confidence: 99%
“…We now have a growing body of literature from around the world that adapting care from traditional models to meet the needs of patients with gout can dramatically improve outcomes. 1…”
Despite effective therapies being available, gout remains a rheumatic disease with poor patient outcomes. Research has identified patient, provider and health system issues as contributing to these poor outcomes. However, there have been a series of studies demonstrating the value of alternate models of care in gout. 1
Objective
Despite increasing overall health care spending over the past several decades, little is known about long‐term patterns of spending among US patients with gout. Current approaches to assessing spending typically focus on composite measures or patients agnostic to disease state; in contrast, examining spending using longitudinal measures may better discriminate patients and target interventions to those in need. We used a data‐driven approach to classify and predict spending patterns in patients with gout.
Methods
Using insurance claims data from 2017–2019, we used group‐based trajectory modeling to classify patients ages 40 years or older diagnosed with gout and treated with urate‐lowering therapy (ULT) by their total health care spending over 2 years. We assessed the ability to predict membership in each spending group using logistic and generalized boosted regression with split‐sample validation. Models were estimated using different sets of predictors and evaluated using C statistics.
Results
In 57,980 patients, the mean ± SD age was 71.0 ± 10.5 years, and 17,194 patients (29.7%) were female. The best‐fitting model included the following groups: minimal spending (13.2%), moderate spending (37.4%), and high spending (49.4%). The ability to predict groups was high overall (e.g., boosted C statistics with all predictors: minimal spending [0.89], moderate spending [0.78], and high spending [0.90]). Although average adherence was relatively high in the population, for the high‐spending group, the most influential predictors were greater gout medication adherence and diabetes melllitus diagnosis.
Conclusion
We identified distinct long‐term health care spending patterns in patients with gout using ULT with high accuracy. Several clinical predictors could be key areas for intervention, such as gout medication use or diabetes melllitus.
Introduction
Gout is commonly associated with low adherence rates, thus limiting the effectiveness of treatment. Nevertheless, informed and empowered patients may be more likely to achieve high adherence. We intend to demonstrate that adherence in clinical practice may reach that achieved in clinical trials.
Methods
This was a transversal study within an inception cohort of patients with gout prospectively followed up. Patients were informed at entrance in the cohort of outcomes, targets, and means to implement for successful treatment. Adherence was evaluated through electronic medication possession ratio (MPR) for urate-lowering medication and oral medications for hypertension, diabetes, and hyperlipidemia for comparison. Factors associated with nonadherence, and the relation between nonadherence and serum urate levels while on treatment were analyzed.
Results
Data were retrieved from 336 patients, who showed a mean MPR of 87.5%, with 82.1% of patients showing MPR ≥ 0.8. Rates of adherence for hypertension, hyperlipidemia, and diabetes were quite similar (88%, 87%, and 83%, respectively), although MPR > 0.8 was significantly lower for oral medications for diabetes. Adherence was lower, but nevertheless quite fair, during the first year of follow-up, and increasing over time. Active follow-up and comorbidity were associated with good adherence, and adherence and long-term follow-up were associated with higher rates of achieving serum urate within therapeutic target.
Conclusion
Patients with gout show high rates of adherence if empowered. Active follow-up and comorbidity are associated with high rates of adherence. Adherence is strongly associated with higher rates of achievement of therapeutic serum urate target.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.